413 filings
Page 4 of 21
8-K
a830d8w18mnsd
3 Aug 22
Kintara Therapeutics Enters Into Equity Purchase Agreement for Up to $20 Million with Lincoln Park Capital
4:06pm
424B5
8lf4ro
3 Aug 22
Prospectus supplement for primary offering
9:07am
8-K
knvc95 2bsb
22 Jun 22
Amendments to Articles of Incorporation or Bylaws
4:15pm
8-K
4w48rnu
16 Jun 22
Kintara Therapeutics Granted Fast Track Designation from the FDA for VAL-083 for Newly-Diagnosed Glioblastoma
9:00am
8-K
em4ud6ag
3 Jun 22
Kintara Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement
9:16am
8-K
cuv14
24 May 22
Departure of Directors or Certain Officers
8:31am
8-K
l16jvocekg8k7791hnt
13 May 22
Kintara Therapeutics Announces Fiscal 2022 Third Quarter Financial Results and Provides Corporate Update
8:15am
DEFA14A
6itu4yg
6 May 22
Additional proxy soliciting materials
4:10pm
8-K
3orfg84j
18 Apr 22
Amendments to Articles of Incorporation or Bylaws
4:37pm
424B5
dwqtg0xt4 wau
13 Apr 22
Prospectus supplement for primary offering
4:16pm
8-K
gdsye8oy5eyp 9vddvd
13 Apr 22
Kintara Announces $8.6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
4:15pm
8-K
iryekh87zsznb84x8p
11 Feb 22
Kintara Therapeutics Announces Fiscal 2022 Second Quarter Financial Results and Provides Corporate Update
8:30am
8-K
w1phvw017wf
8 Feb 22
Departure of Directors or Certain Officers
4:05pm
8-K
q98eh8d8d xmpxmwo
18 Jan 22
Other Events
4:26pm
8-K
d2dzk95i16ehh
10 Jan 22
Other Events
7:17am